Elan Corporation, plc (ADR) - ELN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Elan Corporation, plc (ADR) - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
ELN	New York	2834	http://www.elan.com	11.67 +0.08
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Elan Corporation, plc (ADR) This Week in Biotech - May 18th, 2013 11:45 am The Billion Dollar COPD Deal: Who Gains The Most? - May 17th, 2013 9:27 am Here's What Super-Investor Seth Klarman Has Been Buying - May 16th, 2013 4:46 pm Elan publishes response document regarding Echo Pharma offer - May 15th, 2013 3:21 pm Elan Announces Publication of Response Document - May 15th, 2013 3:14 pm Seth Klarman Buys BP, AIG, Elan Corp, Sells News Corp., Oracle - May 15th, 2013 9:37 am After the close: Edwards discovers the value of stock repurchase plan - May 14th, 2013 4:13 pm Elan in Royalty Deal with THRX - May 14th, 2013 2:00 pm Spectrum Pharma Reports 1Q Loss - May 14th, 2013 7:30 am Who Benefits From This Market Moving Biotechnology Partnership? - May 14th, 2013 6:44 am Stocks Decline Despite Positive Sales Data: Market Recap - May 13th, 2013 6:16 pm ADR REPORT-Japanese ADRs rise 1 pct on yen weakness - May 13th, 2013 4:52 pm Diversifying Royalties at a Hefty Cost - May 13th, 2013 3:40 pm Theravance, Glaxo, Elan Star In Biotech Soap Opera - May 13th, 2013 3:30 pm Blue Chips Decline - May 13th, 2013 2:37 pm Why Did This Biotech Soar? - May 13th, 2013 2:28 pm [video] Solar Stocks Hit 52-Week Highs - May 13th, 2013 2:10 pm Why Theravance Shares Soared Again - May 13th, 2013 11:40 am GM Invests in Its Image, Elan Pays Off Theravance, and 2 More Hot Stocks - May 13th, 2013 11:01 am Analysis: Stock market gains, growth smile on U.S. dollar - Mar 14th, 2013 11:48 pm View All Current Headlines >>